|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Bassim Nasr
CEO | Chief Executive Officer | - | 22/07/2013 |
Maen Hammoudeh
DFI | Director of Finance/CFO | - | 01/01/1997 |
Ayman Qaddumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bassim Nasr
CHM | Chairman | - | 01/01/1986 |
Bassam Yousef
BRD | Director/Board Member | 78 | 01/01/1986 |
Sandra Nasr
BRD | Director/Board Member | 61 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.96% | +3.01% | +59.87% | +173.31% | 1,10200Cr | ||
| +3.05% | +5.23% | +72.11% | +67.81% | 64TCr | ||
| -0.04% | +1.20% | +35.72% | +87.93% | 45TCr | ||
| +0.54% | -2.07% | +27.62% | +22.57% | 34TCr | ||
| -1.07% | -0.71% | +28.76% | +48.02% | 29TCr | ||
| -2.89% | +1.61% | -27.55% | -40.47% | 22TCr | ||
| +0.45% | +1.65% | +25.65% | +68.35% | 20TCr | ||
| +5.21% | +7.93% | +21.99% | +83.23% | 17TCr | ||
| +1.48% | -0.04% | -4.64% | -32.25% | 14TCr | ||
| Average | +0.37% | +2.00% | +26.61% | +53.17% | 39.39TCr | |
| Weighted average by Cap. | +1.29% | +1.86% | +41.76% | +87.39% |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















